Surgical outcomes of hyperthermic intraperitoneal chemotherapy: Analysis of the American College of Surgeons National Surgical Quality Improvement Program

JAMA Surgery

Volumn 149, Issue 2, 2014, Pages 170-175

  Jafari, Mehraneh D ^a   Halabi, Wissam J ^a   Stamos, Michael J ^a   Nguyen, Vinh Q ^b   Carmichael, Joseph C ^a   Mills, Steven D ^a   Pigazzi, Alessio ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b 5226 Donald Bren Hall   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; DIGESTIVE SYSTEM SURGICAL PROCEDURES; FEMALE; FOLLOW-UP STUDIES; HOSPITAL MORTALITY; HUMANS; HYPERTHERMIA, INDUCED; KAPLAN-MEIER ESTIMATE; LENGTH OF STAY; MALE; MIDDLE AGED; PERITONEAL NEOPLASMS; QUALITY IMPROVEMENT; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES;

EID: 84894544530     PISSN: 21686254     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamasurg.2013.3640     Document Type: Article

References (25)

1. Chua TC, Yan TD, Saxena A, Morris DL. Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure? a systematic review of morbidity and mortality. Ann Surg. 2009;249(6):900-907.
2. Carmignani CP, Sugarbaker TA, Bromley CM, Sugarbaker PH. Intraperitoneal cancer dissemination: mechanisms of the patterns of spread. Cancer Metastasis Rev. 2003;22(4): 465-472.
3. Glehen O, Osinsky D, Cotte E, et al. Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: morbidity and mortality analysis of 216 consecutive procedures. Ann Surg Oncol. 2003;10(8):863-869.
4. Arakelian E, Torkzad MR, Bergman A, Rubertsson S, Mahteme H. Pulmonary influences on early post-operative recovery in patients after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy treatment: a retrospective study.World J Surg Oncol. 2012;10:258.
5. de Cuba EM, Kwakman R, Knol DL, Bonjer HJ, Meijer GA, Te Velde EA. Cytoreductive surgery and HIPEC for peritoneal metastases combined with curative treatment of colorectal liver metastases: systematic review of all literature and meta-analysis of observational studies. Cancer Treat Rev. 2012;39(4):321-327.
6. Sadeghi B, Arvieux C, Glehen O, et al. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer. 2000;88(2):358-363.
7. Glehen O, Mohamed F, Gilly FN. Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia. Lancet Oncol. 2004;5(4):219-228.
8. Sugarbaker PH. Peritonectomy procedures. Ann Surg. 1995;221(1):29-42.
9. Chan DL, Morris DL, Rao A, Chua TC. Intraperitoneal chemotherapy in ovarian cancer: a review of tolerance and efficacy. Cancer Manag Res. 2012;4:413-422.
10. Turrini O, Lambaudie E, Faucher M, et al. Initial experience with hyperthermic intraperitoneal chemotherapy. Arch Surg. 2012;147(10):919-923.
11. Roviello F, Pinto E, Corso G, et al. Safety and potential benefit of hyperthermic intraperitoneal chemotherapy (HIPEC) in peritoneal carcinomatosis from primary or recurrent ovarian cancer. J Surg Oncol. 2010;102(6):663-670.
12. Verwaal VJ, van Ruth S, de Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003;21(20):3737- 3743.
13. Sugarbaker PH, Jablonski KA. Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg. 1995;221(2):124-132.
14. Glehen O, Mithieux F, Osinsky D, et al. Surgery combined with peritonectomy procedures and intraperitoneal chemohyperthermia in abdominal cancers with peritoneal carcinomatosis: a phase II study. J Clin Oncol. 2003;21(5):799-806.
15. Sugarbaker PH. Cytoreductive surgery plus hyperthermic perioperative chemotherapy for selected patients with peritoneal metastases from colorectal cancer: a new standard of care or an experimental approach? Gastroenterol Res Pract. 2012:309417.
16. Cavaliere R, Ciocatto EC, Giovanella BC, et al. Selective heat sensitivity of cancer cells: biochemical and clinical studies. Cancer. 1967;20(9):1351-1381.
17. Levine EA, Stewart JH 4th, Russell GB, Geisinger KR, Loggie BL, Shen P. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: experience with 501 procedures [published correction appears in J AmColl Surg. 2007;205(4):630]. J AmColl Surg. 2007;204(5):943-953; discussion 953-955.
18. American College of Surgeons National Surgical Quality Improvement Program. Participant use data file: 2005-2010. http://site.acsnsqip.org/ participant-use-data-file/. Accessed October 19, 2012.
19. Tibshirani R. Regression shrinkage and selection via the lasso. J R Stat Soc Series B Methodol. 1996;(58):267-288.
20. Glehen O, Gilly FN, Boutitie F, et al French Surgical Association. Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1,290 patients. Cancer. 2010;116(24):5608-5618.
21. Glehen O, Kwiatkowski F, Sugarbaker PH, et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol. 2004;22(16):3284-3292.
22. Jaehne J. Cytoreductive procedures-strategies to reduce postoperative morbidity and management of surgical complications with special emphasis on anastomotic leaks. J Surg Oncol. 2009;100(4):302-305.
23. Preti V, Chang D, Sugarbaker PH. Pulmonary complications following cytoreductive surgery and perioperative chemotherapy in 147 consecutive patients. Gastroenterol Res Pract. 2012:635314.
24. Rankovic VI, Masirevic VP, Pavlov MJ, et al. Hemodynamic and cardiovascular problems during modified hyperthermic intraperitoneal perioperative chemotherapy. Hepatogastroenterology. 2007;54(74):364-366.
25. RaueW, Tsilimparis N, Bloch A, Menenakos C, Hartmann J. Volume therapy and cardiocircular function during hyperthermic intraperitoneal chemotherapy. Eur Surg Res. 2009;43(4):365-372.